ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
HP
Hôpital Européen Georges-Pompidou at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Hôpital Européen Georges-Pompidou takes part in 11 sessions at ESMO 2026 in Madrid. Its work focuses on treatment decisions and outcomes across digestive, kidney, prostate and other cancers. It examines approaches that combine immunotherapy and radiotherapy for locally advanced rectal cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
HP Hôpital Européen Georges-Pompidou Paris, France | |
Public teaching hospital in south-west Paris, France, part of the Paris public hospital system (AP-HP). | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Clinical value and significance of the HRD score: Insights from a molecularly profiled pan-tumor cohort included in the French Cancer Plan 2025 (SeqOIA platform) Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancersBreast cancerBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Exposure–response of lenvatinib in patients concomitantly treated with pembrolizumab for advanced renal and endometrial cancers Gynaecological cancersGenitourinary cancers Poster Fri Oct 23 15:15–16:00 Fragmentomics-derived transcriptional activation score refines prognostic stratification in metastatic castration-resistant prostate cancer Genitourinary cancersBiomarkers & precision oncology Talk Sat Oct 24 11:15–11:35 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Talk Mon Oct 26 14:45–15:10 Clinical and biological definitions of oligometastatic disease Gastrointestinal cancers |
Find decision makers at Hôpital Européen Georges-Pompidou
Tell us what you sell and we’ll find the people at Hôpital Européen Georges-Pompidou most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction